New preclinical study shows antibody therapy could offer treatment path for genetic form of ALS
Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.
Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.
Chronic neurological diseases — Alzheimer’s disease, Parkinson’s disease, dystonia, ALS (Lou Gehrig’s disease), Huntington’s disease, neuromuscular disease, multiple sclerosis and epilepsy, to mention only a few — afflict millions of Americans worldwide and account for tremendous morbidity and mortality. Furthermore, age is the largest risk factor for many…